The combinatorial synthesis of bioactive quinoxalines, quinoxalinones and quinoxalinols

Combinatorial Chemistry and High Throughput Screening

Volumn 13, Issue 3, 2010, Pages 293-301

  Lv, Min ^a   Xu, Hui ^a  

^a NORTHWEST A F UNIVERSITY   (China)

Author keywords

Heterocycle; Microwave irradiation; Quinoxaline; Quinoxalinol; Quinoxalinone; Solid phase; Solution phase; Solvent free

Indexed keywords

(3 DIALKYLAMINO 2 METHOXYQUINOXALIN 6 YL)AMINO RESIN DERIVATIVE; 1,2,3,4 TETRAHYDROQUINOXALINE; 11 (1H PYRROL 1 YL)11H INDENO[1,2]QUINOXALINE DERIVATIVE; 4 OXO 4H IMIDAZO [1,5] QUINOXALINE DERIVATIVE; 4 OXO 4H PYRAZOLO [1,5] QUINOXALINE DERIVATIVE; 6 AMINO 2,3 DICHLOROQUINOXALINE; HETEROCYCLIC COMPOUND; QUINOXALINE 1,4 DIOXIDE DERIVATIVE; QUINOXALINE DERIVATIVE; QUINOXALINOL DERIVATIVE; QUINOXALINONE DERIVATIVE; UNCLASSIFIED DRUG;

BIOLOGICAL ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; MICROWAVE RADIATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SOLID PHASE SYNTHESIS;

COMBINATORIAL CHEMISTRY TECHNIQUES; MICROWAVES; MOLECULAR STRUCTURE; QUINOXALINES;

EID: 77949815269     PISSN: 13862073     EISSN: None     Source Type: Journal    
DOI: 10.2174/138620710790980513     Document Type: Review

References (47)

1. Ganapaty, S.; Ramalingam, P.; Baburao, C. Antimicrobial and antimycobacterial activity of some quinoxalines 'N' bridgehead heterocycles. Asian J. Chem., 2008, 20 (5), 3353-3356.
2. Badran, M.M.; Moneer, A.A.; Refaat, H.M.; El-Malah, A.A. Synthesis and antimicrobial activity of novel quinoxaline derivatives. J. Chin. Chem. Soc., 2007, 54(2), 469-478.
3. Villar, R.; Vicente, E.; Solano, B.; Perez-Silanes, S.; Aldana, I.; Maddry, J.A.; Lenaerts, A.J.; Franzblau, S.G.; Cho, S.H.; Monge, A.; Goldman, R.C. In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide. J. Antimicrob. Chemother., 2008, 62, 547-554.
4. Bahekar, R.H.; Jain, M.R.; Gupta, A.A.; Goel, A.; Jadav, P.A.; Patel, D.N.; Prajapati, V.M.; Patel, P.R. Synthesis and antidiabetic activity of 3,6,7-trisubstituted-2-(1H-imidazol-2-ylsulfanyl)quinoxalines and quinoxalin-2-yl isothioureas. Arch. Pharm., 2007, 340(7), 359-366.
5. Abid, M.; Azam, A. Synthesis, characterization and antiamoebic activity of1-(thiazolo[4,5-b]quinoxaline-2-yl)-3-phenyl-2-pyrazoline derivatives. Bioorg. Med. Chem. Lett., 2006, 16(10), 2812-2816.
6. Moarbess, G.; Deleuze-Masquefa, C.; Bonnard, V.; Gayraud-Paniagua, S.; Vidal, J.R.; Bressolle, F.; Pinguet, F.; Bonnet, P.A. In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives. Bioorg. Med. Chem., 2008, 16(13), 6601-6610.
7. Diana, P.; Martorana, A.; Barraja, P.; Montalbano, A.; Dattolo, G.; Cirrincione, G.; Dall'Acqua, F.; Salvador, A.; Vedaldi, D.; Basso, G.; Viola, G. Isoindolo[2,1-a]quinoxaline derivatives, novel potent antitumor agents with dual inhibition of tubulin polymerization and topoisomerase I. J. Med. Chem., 2008, 51(8), 2387-2399.
8. Undevia, S.D.; Innocenti, F.; Ramirez, J.; House, L.; Desai, A.A.; Skoog, L.A.; Singh, D.A.; Karrison, T.; Kindler, H.L.; Ratain, M.J. A phase I and pharmacokinetic study of the quinoxaline antitumour agent R(+)XK469 in patients with advanced solid tumours. Eur. J. Cancer, 2008, 44(12), 1684-1692.
9. Ali, I.A.I.; Al-Masoudi, I.A.; Aziz, N.M.; Al-Masoudi, N.A. New acyclic quinoxaline nucleosides. synthesis and anti-HIV activity. Nucleos. Nucleot. Nucl. Acids, 2008, 27(2), 146-156.
10. Wilhelmsson, L.M.; Kingi, N.; Bergman, J. Interactions of antiviral indolo[2,3-b]quinoxaline derivatives with DNA. J. Med. Chem., 2008, 51(24), 7744-7750.
11. Guillon, J.; Moreau, S.; Mouray, E.; Sinou, V.; Forfar, I.; Fabre, S.B.; Desplat, V.; Millet, P.; Parzy, D.; Jarry, C.; Grellier, P. New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: Synthesis, and in vitro antimalarial activity. Bioorg. Med. Chem., 2008, 16(20), 9133-9144.
12. Desplat, V.; Geneste, A.; Begorre, M.A.; Fabre, S.B.; Brajot, S.; Massip, S.; Thiolat, D.; Mossalayi, D.; Jarry, C.; Guillon, J.J. Synthesis of new pyrrolo[1,2-a]quinoxaline derivatives as potential inhibitors of Akt kinase. Enzym. Inhib. Med. Chem., 2008, 23(5), 648-658.
13. Hui, X.; Desrivot, J.; Bories, C.; Loiseau, P.M.; Franck, X.; Hocquemiller. R.; Figadere, B. Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines. Bioorg. Med. Chem. Lett., 2006, 16(4), 815-820.
14. Jaung, J.Y. Synthesis and halochromism of new quinoxaline fluorescent dyes. Dyes Pigments, 2006, 71, 245-250.
15. Son, H.J.; Han, W.S.; Wee, K.R.; Yoo, D.H.; Lee, J.H.; Kwon, S.N.; Ko, J.; Kang, S.O. Turning on fluorescent emission from C-alkylation on quinoxaline derivatives. Org. Lett., 2008, 10(23), 5401-5404. [16] Davey, D.D.; Erhardt, P.W.; Cantor, E.H.; Greenberg, S.S.; Ingebretsen, W.R.; Wiggins, J. Novel compounds possessing potent cAMP and cGMP phosphodiesterase inhibitory activity. Synthesis and cardiovascular effects of a series of imidazo[1,2-a]quinoxalinones and imidazo[1,5-a]quinoxalinones and their aza analogs. J. Med. Chem., 1991, 34(9), 2671-2677.
16. Lawrence, D.S.; Copper, J.E.; Smith, C.D. Structure??activity studies of substituted quinoxalinones as multiple-drug-resistance antagonists. J. Med. Chem., 2001, 44(4), 594-601.
17. Olayiwola, G.; Obafemi, C.A.; Taiwo, F.O. Synthesis and neuropharmacological activity of some quinoxalinone derivatives. Afr. J. Biotechnol., 2007, 6(6), 777-786.
18. Ohmori, J.; Shimizu-Sasamata, M.; Okada, M.; Sakamoto, S. 8-(1H-Imidazol-1-yl)-7-nitro-4(5H)-imidazo[1,2-a]quinoxalinone and related compounds: synthesis and structure??activity relationships for the AMPA-type non-NMDA receptor. J. Med. Chem., 1997, 40(13), 2053-2063.
19. Obafemi, C.A.; Akinpelu, D.A. Synthesis and antimicrobial activity of some 2(1H)-quinoxalinone-6-sulfonyl derivatives. Phosphorus Sulfur, Silicon Relat. Elem., 2005, 180, 1795-1807.
20. Mensah-Osman, E.J.; Al-Katib, A.M.; Dandashi, M.H.; Mohammad, R.M. 2-[4-(7-Chloro-2-quinoxalinyloxy)phenoxy]-propionic acid (XK469) inhibition of topoisomerase II{beta} is not sufficient for therapeutic response in human waldenstrom's macroglobulinemia xenograft model. Mol. Cancer Ther., 2002, 1(14), 1315-1320.
21. Burke, J.R.; Pattoli, M.A.; Gregor, K.R.; Brassil, P.J.; MacMaster, J.F.; Mclntyre, K.W.; Yang, X.; Iotzova, V.S.; Clarke, W.; Strnad, J.; Qiu, Y.; Zusi, F.C. BMS-345541 is a highly selective inhibitor of I??B kinase that binds at an allosteric site of the enzyme and blocks NF-??B-dependent transcription in mice. J. Biol. Chem., 2003, 278(3), 1450-1456.
22. Zhang, L.; Liu, G.; Zhang, S.D.; Yang, H.Z.; Li, L.; Wu, X.H.; Yu, J.; Kou, B.B.; Xu, S.; Li, J.; Sun, G.C.; Ji, Y.F.; Cheng, G.F. Parallel approach for solution-phase synthesis of 2-quinoxalinol analogues and their inhibition of LPS-induced TNF-alpha release on mouse macrophages in vitro. J. Comb. Chem., 2004, 6(3), 431-434.
23. Wu, X.H.; Gorden, A.E.V. 2-Quinoxalinol salen ligands incorporated into functionalized resins for selective solid-phase extraction of copper(II). Tetrahedron Lett., 2008, 49(35), 5200-5203.
24. a) Wesche, H.; Xiao, S.H.; Young, S. "Spirit" of high throughput screening. Comb. Chem. High Throughput Screen., 2008, 11(3), 174.
25. b) Lesch, B.; Thomson, D.W.; Lindell, S.D. The combinatorial synthesis of organophosphorus compounds. Comb. Chem. High Throughput Screen., 2008, 11(1), 36-61.
26. c) Fagadar-Cosma, E.; Cseh, L.; Badea, V.; Fagadar-Cosma, G.; Vlascici, D. Combinatorial synthesis and characterization of new asymmetric porphyrins as potential photosensitizers in photodynamic therapy. Comb. Chem. High Throughput Screen., 2007, 10(6), 466-472.
27. d) O'Neill, J.C.; Blackwell, H.E. Solid-phase and microwave-assisted syntheses of 857 2,5-diketopiperazines: small molecules with great potential. Comb. Chem. High Throughput Screen., 2007, 10(10), 857-876.
28. e) Lesma, G.; Danieli, B.; Lodroni, F.; Passarella, D.; Sacchetti, A.; Silvani, A. Microwave-assisted, solid-phase synthesis of a chiral 1,2,3,4-tetrahydroquinoline library. Comb. Chem. High Throughput Screen., 2006, 9(9), 691-701.
29. f) Chauhan, P.M.S.; Srivastava, S.K. Recent developments in the combinatorial synthesis of nitrogen heterocycles using solid phase technology. Comb. Chem. High Throughput Screen., 2001, 4(1), 35-51.
30. Kamal, A.; Reddy, K.L.; Devaiah, V.; Shankaraiah, N.; Rao, M.V. Recent advances in the solid-phase combinatorial synthetic strategies for the quinoxaline, quinazoline and benzimidazole based privileged structures. Mini-Rev. Med. Chem., 2006, 6(1), 71-89.
31. Dixon, S.; Wang, X.B.; Lam, K.S.; Kurth, M.J. Solid-phase synthesis of quinoxaline, thiazine, and oxazine analogs through a benzyne intermediate. Tetrahedron Lett., 2005, 46(43), 7443-7446.
32. Staszewska, A.; Stefanowicz, P.; Szewczuk, Z. Direct solid-phase synthesis of quinoxaline-containing peptides. Tetrahedron Lett., 2005, 46(33), 5525-5528.
33. Jeon, M.K.; Kim, D.S.; La, H.J.; Gong, Y.D. Solid-phase synthesis of quinoxaline derivatives using 6-amino-2,3-dichloroquinoxaline loaded on AMEBA resin. Tetrahedron Lett., 2005, 46(30), 4979-4983.
34. Aparicio, D.; Attanasi, O.A.; Filippone, P.; Ignacio, R.; Lillini, S.; Mantellini, F.; Palacios, F.; de los Santos, J.M. Straightforward access to pyrazines, piperazinones, and quinoxalines by reactions of 1,2-diaza-1,3- butadienes with 1,2-diamines under solution, solvent-free, or solid-phase conditions. J. Org. Chem., 2006, 71(16), 5897-5905.
35. Ahmad, S.; Ali, M. An efficient solid acid promoted synthesis of quinoxaline derivatives at room temperature. Chin. J. Chem., 2007, 25(6), 818-821.
36. Srinivas, C.; Kumar, C.N.S.S.P.; Rao, V.J.; Palaniappan, S. Efficient, convenient and reusable polyaniline-sulfate salt catalyst for the synthesis of quinoxaline derivatives.. J. Mol. Catal. A: Chem., 2007, 265(1-2), 227-230.
37. Lima, L.M.; Zarranz, B.; Marin, A.; Solano, B.; Vicente, E.; Silanes, S.P.; Aldana, I.; Monge, A. Comparative use of solventfree KF-Al2O3 and K2CO3 in acetone in the synthesis of quinoxaline 1,4-dioxide derivatives designed as antimalarial drug candidates. J. Heterocyclic Chem., 2005, 42, 1381-1385.
38. Wang, L.M.; Liu, J.J.; Tian, H.; Qian, C.T. Ytterbium triflate catalyzed heterocyclization of 1,2-phenylenediamines and alkyl oxalates under solvent-free conditions via Phillips reaction: a facile synthesis of quinoxaline-2,3-diones derivatives. Synth. Commun., 2004, 34(8), 1349-1357.
39. Zhao, Z.; Wisnoski, D.D.; Wolkenberg, S.E.; Leister, W.H.; Wang, Y.; Lindsley, C.W. General microwave-assisted protocols for the expedient synthesis of quinoxalines and heterocyclic pyrazines. Tetrahedron Lett., 2004, 45(25), 4873-4876.
40. Azizian, J.; Karimi, A.R.; Kazemizadeh, Z.; Mohammadi, A.A.; Mohammadizadeh, M.R. A synthetic route to 11-(1H-pyrrol-1-yl)-11H-indeno[1,2-b]quinoxaline derivatives exploiting a three-component coupling strategy under microwave irradiation. Tetrahedron Lett., 2005, 46(36), 6155-6157.
41. Kim, S.Y.; Park, K.H.; Chung, Y.K. Manganese(IV) dioxide-catalyzed synthesis of quinoxalines under microwave irradiation. Chem. Commun., 2005, 1321-1323.
42. Zhou, J.F.; Gong, G.X.; An, L.T.; Liu, Y.; Zhu, F.X.; Zhu, Y.L.; Ji, S.J. An efficient synthesis of quinoxalines under catalyst-free and microwave-irradiation conditions. Synlett, 2008, 20, 3163-3166.
43. Tung, C.; Sun, C. Liquid phase synthesis of chiral quinoxalinones by microwave irradiation. Tetrahedron Lett., 2004, 45(6), 1159-1162.
44. Zhang, W. Fluorous technologies for solution-phase highthroughput organic synthesis. Tetrahedron, 2003, 59(25), 4475-4489.
45. Zhang, W.; Tempest, P. Highly efficient microwave-assisted fluorous Ugi and post-condensation reactions for benzimidazoles and quinoxalinones. Tetrahedron Lett., 2004, 45(36), 6757-6760.
46. Spatz, J.H.; Umkehrer, M.; Kalinski, C.; Ross, G.; Burdack, C.; Kolb, J.; Bach, T. Combinatorial synthesis of 4-oxo-4H-imidazo [1,5-a]quinoxalines and 4-oxo-4H-pyrazolo[1,5-a] quinoxalines. Tetrahedron Lett., 2007, 48(45), 8060-8064.
47. Gris, J.; Glisoni, R.; Fabian, L.; Fernandez, B.; Moglioni, A.G. Synthesis of potential chemotherapic quinoxalinone derivatives by biocatalysis or microwave-assisted Hinsberg reaction. Tetrahedron Lett., 2008, 49(6), 1053-1056.